Search Results - Alshaker, Heba
- Showing 1 - 17 results of 17
-
1
-
2
-
3
-
4
-
5
-
6
-
7
-
8
-
9
-
10
Eriobotrya japonica hydrophilic extract modulates cytokines in normal tissues, in the tumor of Meth-A-fibrosarcoma bearing mice, and enhances their survival time by Alshaker, Heba A, Qinna, Nidal A, Qadan, Fadi, Bustami, Mona, Matalka, Khalid Z
Published 2011Text -
11
Core shell lipid-polymer hybrid nanoparticles with combined docetaxel and molecular targeted therapy for the treatment of metastatic prostate cancer by Wang, Qi, Alshaker, Heba, Böhler, Torsten, Srivats, Shyam, Chao, Yimin, Cooper, Colin, Pchejetski, Dmitri
Published 2017Text -
12
-
13
-
14
Everolimus (RAD001) sensitizes prostate cancer cells to docetaxel by down-regulation of HIF-1α and sphingosine kinase 1 by Alshaker, Heba, Wang, Qi, Kawano, Yoshiaki, Arafat, Tawfiq, Böhler, Torsten, Winkler, Mathias, Cooper, Colin, Pchejetski, Dmitri
Published 2016Text -
15
Combination of RAD001 (everolimus) and docetaxel reduces prostate and breast cancer cell VEGF production and tumour vascularisation independently of sphingosine-kinase-1 by Alshaker, Heba, Wang, Qi, Böhler, Torsten, Mills, Robert, Winkler, Mathias, Arafat, Tawfiq, Kawano, Yoshiaki, Pchejetski, Dmitri
Published 2017Text -
16
Leptin induces upregulation of sphingosine kinase 1 in oestrogen receptor-negative breast cancer via Src family kinase-mediated, janus kinase 2-independent pathway by Alshaker, Heba, Krell, Jonathan, Frampton, Adam E, Waxman, Jonathan, Blyuss, Oleg, Zaikin, Alexey, Winkler, Mathias, Stebbing, Justin, Yagüe, Ernesto, Pchejetski, Dmitri
Published 2014Text -
17
Chromatin conformation changes in peripheral blood can detect prostate cancer and stratify disease risk groups by Alshaker, Heba, Mills, Robert, Hunter, Ewan, Salter, Matthew, Ramadass, Aroul, Skinner, Benjamin Matthew, Westra, Willem, Green, Jayne, Akoulitchev, Alexandre, Winkler, Mathias, Pchejetski, Dmitri
Published 2021Text